Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest Articles
Teeter AE et al. – Although early PSA doubling time (ePSADT) and PSADT were significantly related, the overall correlation was poor. However, a long ePSADT correlated well with a long PSADT and is thus useful in identifying men at low risk for prostate cancer-specific mortality very early in their biochemical recurrence (BCR).
Methods- Aim was to determine if ePSADT correlated with 'standard' PSADT following BCR
- Spearman's correlation was used to determine the correlation between ePSADT and PSADT among 157 men
- These men underwent RP between 1988 and 2005 and had a calculable ePSADT and PSADT
- ePSADT threshold was examined and their positive and negative predictive values (PPV and NPV, respectively), to predict aggressive recurrences (PSADT of <9 mo)
- ePSADT was significantly, though poorly, correlated with PSADT
- ePSADT more accurately predicted PSADT among men with a long ePSADT
- Of men with an ePSADT of ≥20 or ≥15 mo, the NPV for an aggressive recurrence was 98% and 93%, respectively
- However, among men with an ePSADT of <3 mo, the PPV for aggressive recurrence was only 39%
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09
Today in Radiology/Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
Bacterial Sepsis After Prostate Biopsy—A New Perspective
Urology, 10/21/09
Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence
Journal of Clinical Oncology, 11/02/09
Sonographic detection of renal and ureteral stones. Value of the twinkling sign
International Braz J Urol, 10/30/09
Article Search
Sponsor